Heron Therapeutics Inc (HRTX)
2.455
-0.10
(-3.73%)
USD |
NASDAQ |
Apr 26, 16:00
2.455
0.00 (0.00%)
After-Hours: 20:00
Heron Therapeutics Debt to Equity Ratio: -5.114 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | -5.114 |
| September 30, 2023 | -6.243 |
| June 30, 2023 | -3.803 |
| March 31, 2023 | -13.07 |
| December 31, 2022 | 11.00 |
| September 30, 2022 | 6.647 |
| June 30, 2022 | -6.863 |
| March 31, 2022 | 6.225 |
| December 31, 2021 | 1.922 |
| September 30, 2021 | 1.254 |
| June 30, 2021 | 0.9305 |
| March 31, 2021 | 0.0385 |
| December 31, 2020 | 0.0298 |
| September 30, 2020 | 0.0239 |
| June 30, 2020 | 0.0193 |
| March 31, 2020 | 0.0162 |
| December 31, 2019 | 0.0139 |
| September 30, 2019 | 0.0188 |
| June 30, 2019 | 0.0166 |
| March 31, 2019 | 0.0145 |
| December 31, 2018 | 0.0124 |
| September 30, 2018 | 0.0107 |
| June 30, 2018 | 0.0674 |
| March 31, 2018 | 0.3134 |
| December 31, 2017 | 0.2187 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.7111 |
| June 30, 2017 | 0.4095 |
| March 31, 2017 | 0.5197 |
| December 31, 2016 | -2.490 |
| September 30, 2016 | 2.949 |
| June 30, 2016 | 0.0442 |
| March 31, 2016 | 0.0258 |
| December 31, 2015 | 0.0188 |
| September 30, 2015 | 0.0145 |
| June 30, 2015 | 0.0119 |
| March 31, 2015 | 0.0364 |
| December 31, 2014 | 0.0253 |
| September 30, 2014 | 0.0179 |
| June 30, 2014 | 0.0133 |
| March 31, 2014 | 0.021 |
| December 31, 2013 | 0.0149 |
| September 30, 2013 | 0.0425 |
| June 30, 2013 | 0.0265 |
| March 31, 2013 | 0.015 |
| December 31, 2012 | 0.0095 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.0065 |
| September 30, 2011 | 0.0033 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-13.07
Minimum
Mar 2023
11.00
Maximum
Dec 2022
-0.365
Average
0.0193
Median
Jun 2020
Debt to Equity Ratio Benchmarks
| United Therapeutics Corp | 0.117 |
| Esperion Therapeutics Inc | -0.5749 |
| Aldeyra Therapeutics Inc | -- |
| Ocular Therapeutix Inc | 0.8222 |
| Clearside Biomedical Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 222.51M |
| Total Liabilities (Quarterly) | 256.48M |
| Shareholders Equity (Quarterly) | -33.97M |
| Current Ratio | 2.369 |
| Net Debt Paydown Yield | -1.92% |